Navigation Links
Mouse Model of Age-Related Macular Degeneration Developed
Date:1/28/2008

Researchers say it will allow for testing of new drugs for vision-robbing disease

MONDAY, Jan. 28 (HealthDay News) -- The first animal model of age-related macular degeneration (AMD) has been developed by Cleveland Clinic researchers.

This mouse model will help improve knowledge about the development and progression of the disease and will enable pre-clinical testing of new drugs for AMD, a leading cause of blindness in the elderly.

The researchers created this animal model of AMD by modifying specific proteins found in mouse blood, forcing the immune system to mount a response that led to the development of the characteristics of AMD.

"More than 8 million Americans are living with vision loss caused by AMD, and 250,000 new cases are diagnosed each year," research team leader Joe G. Hollyfield, of Cleveland Clinic's Cole Eye Institute, said in a prepared statement.

"The discovery of the animal model of AMD presents a significant opportunity to efficiently and effectively develop and test novel therapies to both prevent the disease and slow vision loss. Research conducted today may one day help find a cure for this progressive disease," Hollyfield said.

The creation of the mouse AMD model is described in a report in the Jan. 27 online edition of Nature Medicine.

AMD is the most common cause of vision loss among American adults aged 60 and older. The disease gradually destroys sharp, central vision, which is needed for seeing objects clearly and for common daily tasks such as reading and driving.

More information

The U.S. National Eye Institute has more about age-related macular degeneration.



-- Robert Preidt



SOURCE: Cleveland Clinic, news release, Jan. 27, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Effectiveness of mouse breeds that mimic Alzheimers disease symptoms questioned
2. Mouse vision has a rhythm all its own
3. Mouse Study Gives Clues to Colitis
4. Mouse mammary tumor virus can replicate in human cells
5. A longer-living, healthier mouse that could hold clues to human aging
6. Gene Tweak Reverses Aging in Mouse Skin Cells
7. Chromatin remodeling complex connected to DNA damage control
8. Health care incentive model offers collaborative approach
9. Novel 3-D cell culture model shows selective tumour uptake of nanoparticles
10. 4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, to Address National Drug Crisis, Keynote Grand Opening of New Allenwood, PA National Model Detox Center
11. A classic method for modeling skin cancer is featured in Cold Spring Harbor Protocols
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Mouse Model of Age-Related Macular Degeneration Developed
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, and ... in the eye of the beholder, according to experts who offered insights and commentary ... of Managed Care. For the full issue, click here . , For the ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women ... diagnosed with endometriosis. These women need a treatment plan to not only alleviate ... that can help for preservation of fertility and ultimately achieving a pregnancy. The ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... First ... United States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell ... facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive ...
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Global law ... magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition are ... , Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: